Voyager Therapeutics, Inc. (VYGR) Total assets 2016–2025
Voyager Therapeutics, Inc. (VYGR) total assets at each fiscal year-end, per SEC filings.
$252.3MFY2025 · since FY2016: $189.6M → $252.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $252.3M | -35.8% |
| FY2024 | $393.1M | +11.9% |
| FY2023 | $351.3M | +120.4% |
| FY2022 | $159.4M | -17.8% |
| FY2021 | $193.9M | -25.9% |
| FY2020 | $261.6M | -26.3% |
| FY2019 | $354.8M | +100.4% |
| FY2018 | $177.0M | -4.0% |
| FY2017 | $184.5M | -2.7% |
| FY2016 | $189.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More VYGR financial trends
VYGR RevenueVYGR Net incomeVYGR Net marginVYGR Gross profitVYGR Gross marginVYGR Operating incomeVYGR Operating marginVYGR Operating cash flowVYGR Free cash flowVYGR Capital expendituresVYGR Return on equityVYGR Stock buybacksVYGR Dividends paidVYGR Total liabilitiesVYGR Shareholders’ equityVYGR overview →